BHAGIRADHA CHEMICALS & INDUSTRIES LTD.

Bhagiradha Chemicals & Industries Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 01, 2026, until 48 hours after the declaration of the un-audited financial results for the quarter and half-year ended September 30, 2026. The specific date for the Board of Directors' meeting to approve these results will be communicated later.

Bhagiradha Chemicals & Industries Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results, which were reviewed by the Audit Committee and recommended by the Statutory Auditors. The results cover the period of Q1 FY27.

Bhagiradha Chemicals & Industries reported consolidated revenue of ₹195.02 Cr for Q1 FY27, up 57.6% YoY (₹123.78 Cr) and 23.3% QoQ (₹158.10 Cr), with consolidated PAT of ₹13.33 Cr — up ~235% YoY (₹3.98 Cr) and ~227% QoQ (₹4.07 Cr). Consolidated EPS was ₹1.03 versus ₹0.31 in both the year-ago and preceding quarters. There were no exceptional items in either period, so this is a genuine operating print rather than a one-off-driven number. The scale of the YoY jump is not organic to the parent alone: standalone PAT was ₹10.68 Cr, up a comparatively modest 28.9% YoY (₹8.29 Cr), and standalone revenue of ₹173.67 Cr grew 40.3% YoY versus the parent's own base. The gap between standalone (+28.9%) and consolidated (+235%) PAT growth is driven entirely by wholly-owned subsidiary Bheema Fine Chemicals, which swung from an implied ₹4.31 Cr loss in Q1 FY26 (consolidated PAT of ₹3.98 Cr sat below standalone PAT of ₹8.29 Cr that quarter) to an implied ₹2.65 Cr profit this quarter. That subsidiary turnaround, rather than any change at the parent, is the reason the consolidated headline dramatically outpaces the standalone one — both figures are genuine, but readers seeing only the standalone number would see a much smaller improvement. Margins expanded across the board: consolidated operating margin rose to 15.65% from 7.26% YoY and 12.28% QoQ, while net margin improved to 6.84% from 3.21% YoY and 2.58% QoQ, consistent with the subsidiary's swing to profitability lifting group-level cost absorption. No street/consensus estimates could be verified for this stock — a web search returned figures for the similarly named but unrelated Bhageria Industries, which is not this company, so vsStreet is marked unknown rather than relying on that mismatch. The company and our records carry no formal management guidance or prior concall commentary, and no press release beyond the regulatory filing was available, so there is no outlook to grade the print against; the filing itself only carries board-meeting administrative notes (AGM, BRSR filing, trading-window closure) with no direct bearing on this quarter's numbers. Both the standalone and consolidated statements carry an unmodified limited-review opinion from the statutory auditors.

Bhagiradha Chemicals & Industries Ltd has announced a Board of Directors meeting scheduled for August 3, 2026, in Hyderabad. The primary agenda is to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) for the first quarter ended June 30, 2026, along with the Statutory Auditors' Limited Review Report. Additionally, the company has informed about the closure of the 'Trading Window' for designated persons and their relatives from July 1, 2026, until 48 hours after the declaration of the financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations.

Bhagiradha Chemicals & Industries Ltd has sent a letter to shareholders who have not registered their email addresses, providing a web-link to the complete Annual Report for FY 2025-26. This action is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The letter also informs shareholders about the upcoming 33rd Annual General Meeting (AGM) scheduled for July 31, 2026, to be held via Video Conferencing (VC)/ Other Audio Visual Means (OAVM). Shareholders are urged to update their KYC details, including PAN, email, and bank information, with their respective Depository Participants or the Company/RTA to ensure they continue receiving important communications.

Bhagiradha Chemicals & Industries Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. The report, filed as per SEBI regulations, forms part of the company's Annual Report. It details corporate identity, business activities primarily in agrochemical manufacturing (100% turnover from insecticides, fungicides, herbicides, and intermediates), operational locations, market reach (18 states nationally, 5 countries internationally), employee statistics, and gender representation. Exports constitute 2.50% of total revenue. The company operates on a standalone reporting basis and has not obtained external assurance for the BRSR.

Bhagiradha Chemicals & Industries Ltd has announced its 33rd Annual General Meeting (AGM) will be held on July 31, 2026, at 11:00 a.m. IST via Video Conferencing (VC)/ Other Audio Visual Means (OAVM). The meeting will transact ordinary business including the adoption of audited standalone and consolidated financial statements for FY 2025-26, declaration of a 15% final dividend (₹0.15 per equity share), and the re-appointment of Sri. Suresh Kumar Somani as a director. The Annual Report for FY 2025-26, along with the AGM notice, will be sent electronically on July 8, 2026, to eligible members.

Bhagiradha Chemicals & Industries Ltd has announced its 33rd Annual General Meeting (AGM) for the financial year 2025-26. The AGM is scheduled for Friday, July 31, 2026, at 11:00 a.m. IST and will be conducted via Video Conferencing (VC)/ Other Audio Visual Means (OAVM). The Annual Report for FY 2025-26 and the notice for the AGM are being sent electronically to members registered by July 03, 2026. Shareholders without registered email addresses will receive a web-link to access the complete Annual Report. The report highlights the company's transition into a 'new orbit of growth' driven by innovation, manufacturing leadership, and global competitiveness, powered by its Bhagiradha and Bheema facilities.

Bhagiradha Chemicals & Industries Ltd has announced the closure of its trading window for dealing in equity shares. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut for all designated persons and their immediate relatives from July 01, 2026, until 48 hours after the declaration of the Un-audited Financial Results (Standalone & Consolidated) for the first quarter ended June 30, 2026. The specific date for the Board of Directors' meeting to approve these results will be communicated later.

Bhagiradha Chemicals & Industries Ltd has extended a corporate guarantee of ₹30 Crores on behalf of its wholly-owned subsidiary, Bheema Fine Chemicals Private Limited. This guarantee is in favor of ICICI Bank Limited to secure credit limits sanctioned to the subsidiary. The company stated that the promoter/promoter group has no interest in this transaction, and it is conducted on an arm's length basis. The guarantee will be reflected as a contingent liability in Bhagiradha's books, with no immediate impact on the company's financial position.